Page 243

ticularly assessment of the relative risk of progression to other drugs following marijuana use.

·      Review of the literature determining which chemical components of crude marijuana are responsible for possible therapeutic effects and for side effects.

Therapeutic Use

·      Evaluation of any conclusions on the medical use of marijuana drawn by other groups.

·      Efficacy and side effects of various delivery systems for marijuana compared to existing medications for glaucoma, wasting syndrome, pain, nausea, or other symptoms.

·      Differential effects of various forms of marijuana that relate to age or type of disease.

Economics

·      Costs of various forms of marijuana compared with costs of existing medications for glaucoma, wasting syndrome, pain, nausea, or other symptoms.

·      Assessment of the differences between marijuana and existing medications in terms of access and availability.

These specific areas along with the assessments described above will be integrated into a broad description and assessment of the available literature relevant to the medical use of marijuana.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement